Marco Folini
0000-0002-1811-4407
Fondazione IRCCS Istituto Nazionale dei Tumori
58 papers found
Refreshing results…
Use of ribozymes in validation of targets involved in tumor progression
Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells
Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells
Photochemical internalization of a peptide nucleic acid targeting the catalytic subunit of human telomerase
Radiosensitization of Human Melanoma Cells by Ribozyme-Mediated Inhibition of Survivin Expression
Approaches for the Inhibition of Human Telomerase Based on the Use of Peptide Nucleic Acids and Hammerhead Ribozymes
Targetin g Human Tel omerase by Antisens e Oligonucleotides and Ribozymes
Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis
Possible Regulation of Telomerase Activity by Transcription and Alternative Splicing of Telomerase Reverse Transcriptase in Human Melanoma
Attenuation of telomerase activity does not increase sensitivity of human melanoma cells to anticancer agents
Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells
Telomerase activity and telomere length in human ovarian cancer and melanoma cell lines: correlation with sensitivity to DNA damaging agents.
Inhibition of Telomerase Activity by a Hammerhead Ribozyme Targeting the RNA Component of Telomerase in Human Melanoma Cells
Macrophage populations of different origins have distinct susceptibilities to lipid peroxidation induced by β-haematin (malaria pigment)
Telomerase Activity in Benign and Malignant Breast Lesions: a Pilot Prospective Study on Fine-Needle Aspirates
Schedule-dependent modulation of idarubicin cytotoxicity by lonidamine in human lymphoma cell lines
Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells
Validation of Telomerase and Survivin as Anticancer Therapeutic Targets Using Ribozymes and Small-Interfering RNAs
Missing publications? Search for publications with a matching author name.